GR852996B - - Google Patents

Info

Publication number
GR852996B
GR852996B GR852996A GR850102996A GR852996B GR 852996 B GR852996 B GR 852996B GR 852996 A GR852996 A GR 852996A GR 850102996 A GR850102996 A GR 850102996A GR 852996 B GR852996 B GR 852996B
Authority
GR
Greece
Application number
GR852996A
Other languages
Greek (el)
Inventor
Josef Dr Roch
Armin Dr Heckel
Josef Dr Nickl
Erich Dr Muller
Berthold Dr Narr
Rainer Dr Zimmermann
Hans Dr Weisenberger
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of GR852996B publication Critical patent/GR852996B/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • C07D475/06Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
GR852996A 1984-12-12 1985-12-12 GR852996B (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843445298 DE3445298A1 (de) 1984-12-12 1984-12-12 Neue pteridine, verfahren zu ihrer herstellung und deren verwendung als zwischenprodukte oder als arzneimittel

Publications (1)

Publication Number Publication Date
GR852996B true GR852996B (enExample) 1986-04-16

Family

ID=6252576

Family Applications (1)

Application Number Title Priority Date Filing Date
GR852996A GR852996B (enExample) 1984-12-12 1985-12-12

Country Status (15)

Country Link
EP (1) EP0185259A3 (enExample)
JP (1) JPS61140585A (enExample)
AU (1) AU576924B2 (enExample)
CA (1) CA1252783A (enExample)
DE (1) DE3445298A1 (enExample)
DK (1) DK161327C (enExample)
ES (1) ES8707238A1 (enExample)
FI (1) FI82696C (enExample)
GR (1) GR852996B (enExample)
IL (1) IL77294A (enExample)
NO (1) NO161373C (enExample)
NZ (1) NZ214522A (enExample)
PH (1) PH24451A (enExample)
PT (1) PT81650B (enExample)
ZA (1) ZA859462B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7276506B2 (en) 1998-12-28 2007-10-02 4 Aza Bioscience Nv Immunosuppressive effects of pteridine derivatives
CA2451800A1 (en) 2001-06-28 2003-01-09 Essential Therapeutics, Inc. Fused pyrimidines as d-alanyl-d-alanine ligase inhibitors
DE10202468A1 (de) * 2002-01-23 2004-09-30 Faustus Forschungs Cie. Translational Cancer Research Gmbh Pteridinderivate, Verfahren zu deren Herstellung und ihre Verwendung
DE602004009696T2 (de) * 2003-08-29 2008-08-28 4 Aza Ip Nv Immunosuppressive wirkungen von pteridinderivativen
ES2293354T3 (es) * 2003-10-17 2008-03-16 4 Aza Ip Nv Derivados de pteridina sustituidos por heterociclos y su uso en terapia.
GB2407089A (en) * 2003-10-17 2005-04-20 4 Aza Bioscience Nv Pteridine derivatives
CA2555867A1 (en) * 2004-03-04 2005-09-22 Neurogen Corporation Arylalkylamino-substituted quinazoline analogues
DE102004057595A1 (de) 2004-11-29 2006-06-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Substituierte Pteridine zur Behandlung von entzündlichen Erkrankungen
DE102004057618A1 (de) 2004-11-29 2006-06-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Substituierte Pteridine zur Behandlung von entzündlichen Erkrankungen
DE102004057594A1 (de) 2004-11-29 2006-06-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Substitueirte Pteridine zur Behandlung von entzündlichen Erkrankungen
DE102004057645A1 (de) * 2004-11-29 2006-06-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Substituierte Pteridine zur Behandlung von entzündlichen Erkrankungen
RU2445315C2 (ru) * 2005-11-22 2012-03-20 Кудос Фармасьютиклз Лимитед ПРОИЗВОДНЫЕ ПИРИДО-, ПИРАЗО- И ПИРИМИДО-ПИРИМИДИНА И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ИНГИБИТОРОВ mTOR
WO2007060404A1 (en) * 2005-11-22 2007-05-31 Kudos Pharmaceuticals Limited PYRIDO-,PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
JP5440934B2 (ja) 2006-05-24 2014-03-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 置換プテリジン
WO2008009078A2 (en) 2006-07-20 2008-01-24 Gilead Sciences, Inc. 4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
US10144736B2 (en) 2006-07-20 2018-12-04 Gilead Sciences, Inc. Substituted pteridines useful for the treatment and prevention of viral infections
HUE033894T2 (en) 2006-08-23 2018-01-29 Kudos Pharm Ltd 2-Methylmorpholine pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as MTOR inhibitors
UY31917A (es) 2008-06-20 2010-01-29 Astrazeneca Ab Compuestos de pirido-pirimidina inhibidores de mtor, composiciones farmaceuticas que los comprenden, procesos para su preparación y su uso como medicamento.
KR102394917B1 (ko) 2015-03-04 2022-05-09 길리애드 사이언시즈, 인코포레이티드 톨 유사 수용체 조정제 화합물
WO2018045150A1 (en) 2016-09-02 2018-03-08 Gilead Sciences, Inc. 4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators
PT3507276T (pt) 2016-09-02 2022-01-11 Gilead Sciences Inc Compostos moduladores do recetor de tipo toll
TW202210480A (zh) 2019-04-17 2022-03-16 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TWI751517B (zh) 2019-04-17 2022-01-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TWI879779B (zh) 2019-06-28 2025-04-11 美商基利科學股份有限公司 類鐸受體調節劑化合物的製備方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3159628A (en) * 1962-05-28 1964-12-01 Smith Kline French Lab Pteridine-5-oxide derivatives
DE3323932A1 (de) * 1983-07-02 1985-01-10 Dr. Karl Thomae Gmbh, 7950 Biberach Neue 2-piperazino-pteridine, verfahren zu ihrer herstellung und diese verbindung enthaltende arzneimittel

Also Published As

Publication number Publication date
FI854862A0 (fi) 1985-12-10
EP0185259A3 (de) 1989-03-01
JPS61140585A (ja) 1986-06-27
FI854862A7 (fi) 1986-06-13
NZ214522A (en) 1988-07-28
FI82696C (fi) 1991-04-10
AU576924B2 (en) 1988-09-08
PT81650A (de) 1986-01-01
ES8707238A1 (es) 1987-07-16
PH24451A (en) 1990-06-25
NO854965L (no) 1986-06-13
DE3445298A1 (de) 1986-06-12
DK572685D0 (da) 1985-12-11
DK572685A (da) 1986-06-13
DK161327C (da) 1991-12-09
CA1252783A (en) 1989-04-18
DK161327B (da) 1991-06-24
ZA859462B (en) 1987-07-29
NO161373C (no) 1989-08-09
AU5123285A (en) 1986-06-19
ES549806A0 (es) 1987-07-16
NO161373B (no) 1989-05-02
FI82696B (fi) 1990-12-31
IL77294A (en) 1989-02-28
EP0185259A2 (de) 1986-06-25
PT81650B (pt) 1988-04-21

Similar Documents

Publication Publication Date Title
AT379850B (enExample)
AU2557584A (enExample)
AU2219783A (enExample)
BG45158A1 (enExample)
BG45163A1 (enExample)
BE900712A (enExample)
BG38294A1 (enExample)
BG39778A1 (enExample)
BG44718A1 (enExample)
BG44723A1 (enExample)
BG44737A1 (enExample)
BG44749A1 (enExample)
BG44806A1 (enExample)
BG44829A1 (enExample)
BG44830A1 (enExample)
BG44848A1 (enExample)
BG44917A1 (enExample)
BG44933A1 (enExample)
BG44935A1 (enExample)
BG45160A1 (enExample)
BG45054A1 (enExample)
BG45060A1 (enExample)
BG45079A1 (enExample)
BG45080A1 (enExample)
BG45091A1 (enExample)